Genmab A/S Sponsored ADR (GMAB)
NASDAQ
33.02
-0.43 (-1.29%)
Closed
Aug 24, 2026
Day's Range
32.7433.32
52 wk Range
23.6235.43
Financial Statements - GMAB - Genmab A/S Sponsored ADR
Revenue
3.72B▲ 684.2%
Net Income
963.00M▲ 457.1%Net Margin 25.9%
EBITDA
1.45B▲ 687.2%
Free Cash Flow
1.13B▲ 587.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.72B | 474.36M | 16.47B | 14.50B | 8.41B | 10.11B |
| Cost of Goods | 238M | 21.70M | 226M | 0 | 0 | - |
| Gross Profit | 3.48B | 452.65M | 16.24B | 14.50B | 8.41B | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.25B | 154.32M | 5.32B | 6.26B | 2.95B | 6.31B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -123M | 28.33M | -596M | 375M | 781M | -583M |
| Pre Tax Income | 1.20B | 201.94M | 5.63B | 6.94B | 3.91B | 5.90B |
| Income Tax | 241M | 29.08M | 1.28B | 1.49B | 961M | 1.14B |
| Net Income | 963M | 172.85M | 4.35B | 5.45B | 2.95B | 4.75B |
| EPS Basic | 1.55 | 1.705034 | 6.664 | 8.445 | 4.6 | 7.3 |
| EPS Diluted | 1.537 | 1.693175 | 6.602 | 8.365 | 4.554 | 7.221 |
| Basic Shares Outstanding | 621.51M | 641.86M | 4.66B | 4.73B | 4.72B | 4.69B |
| Diluted Shares Outstanding | 621.51M | 641.86M | 4.66B | 4.73B | 4.72B | 4.69B |
| Ebit | 1.26B | 204.58M | 5.66B | 6.96B | 3.93B | 5.91B |
| Ebitda | 1.45B | 185.35M | 6.55B | 6.95B | 3.39B | 6.75B |
| Net Income Continuous Operations | 1.20B | 201.94M | 5.63B | 6.94B | 3.91B | 5.90B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
